In a preliminary survey of TCGA, we noticed that among various glycosyltransferases involved in colon cancer, B4GALNT2 displayed a very good predictive potential in that patients retaining higher levels of B4GALNT2 mRNA displayed a much longer overall survival. This evidence concerns the gene B4GALNT2 and colonic neoplasm.